MXD1 and central nervous system cancer: tRF-22 negatively regulates MAX dimerization protein 1 (MXD1) expression by binding to its 3′UTR, thereby weakening MXD1's transcriptional suppression of hypoxia-inducible factor 1 alpha (HIF1A) and promoting glioma vascular mimicry (VM) formation [74].